Home » Topics » BioWorld Science

BioWorld Science
RSS

XPO5 gene polymorphism found to protect from coronary artery disease risk

Sep. 4, 2018

In rare encephalitis, neurons contribute to their own demise

Sep. 4, 2018

Dogs and Duchenne

Sep. 4, 2018

Filoviruses hide out in sperm production site

Sep. 4, 2018

AstraZeneca conducts first-in-human study of AZD-8154 in healthy subjects

Sep. 3, 2018

New phase II trial investigates MT-3724 with GEMOX in NHL

Sep. 3, 2018

Incyte studies INCAGN-02385 in phase I for advanced malignancies

Sep. 3, 2018

European Commission approves Cablivi for acquired thrombotic thrombocytopenic purpura

Sep. 3, 2018

FDA issues complete response letter for dasotraline NDA for ADHD

Sep. 3, 2018

Cavion divulges new calcium channel inhibitors

Sep. 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...